Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2

Experimental Cell Research

Volumn 254, Issue 1, 2000, Pages 180-188

  Kurata, Hisashi ^a   Thant, Aye Aye ^a   Matsuo, Seiichi ^a   Senga, Takeshi ^a   Okazaki, Kenji ^b   Hotta, Nigishi ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BIOMOL ENG RESEARCH INSTITUTE   (Japan)

Author keywords

Concanavalin A; MAP kinase; MEK; MMP 2; Signaling pathway; v Src

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CONCANAVALIN A; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL TRANSFORMATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME RELEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034627774     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4738     Document Type: Article

References (35)

1. Liotta L. A. Tumor invasion and metastases - Role of the extracellular matrix. Cancer Res. 46:1986;1-7.
2. Woessner J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
3. Kleiner D. E. Jr., Stetler-Stevenson W. G. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5:1993;891-897.
4. Stetler-Stevenson W. G., Krutzsch H. C., Wacher M. P., Margulies I. M., Liotta L. A. The activation of human typeIV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264:1989;1353-1356.
5. Sato H., Takino T., Okada Y., Cao J., Shinagawa E., Yamamoto M., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 370:1994;61-65.
6. Kataoka M., Yamagata S., Akiyama S., Watanabe T., Takagi H., Thant A. A., Iida K., Saga S., Kishi J., Hamaguchi M. Matrix metalloproteinase 2 and 9 in esophageal cancer: Correlation with organ metastasis. Int. J. Oncol. 8:1996;773-779.
7. Hamaguchi M., Yamagata S., Thant A. A., Xiao H., Iwata H., Mazaki T., Hanafusa H. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src. Oncogene. 10:1995;1037-1043.
8. Thant, A. A, Sein, T. T, Liu, E, Machida, K, Kikkawa, F, Koike, T, Seiki, M, Matsuda, S, and, Hamaguchi, M. Ras pathway is required for the activation of MMP-2 secretion and for the invasion of src-transformed 3Y1, Oncogene. [in press].
9. Jove R., Hanafusa H. Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol. 3:1987;31-56.
10. c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA. 84:1987;2251-2255.
11. Ottenhoff-Kalff A. E., Rijksen G., van Beurden E. A., Hennipman A., Michels A. A., Staal G. E. Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res. 52:1992;4773-4778.
12. Irby R. B., Mao W., Coppola D., Kang J., Loubeau J. M., Trudeau W., Karl R., Fujita D. J., Jove R., Yeatman T. J. Activating SRC mutation in a subset of advanced human colon cancers. Nature Genet. 21:1999;187-190.
13. Thant A. A., Serbulea M., Kikkawa F., Liu E., Tomoda Y., Hamaguchi M. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett. 406:1997;28-30.
14. Feig L. A., Cooper G. M. Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cel. Biol. 8:1988;3235-3243.
15. Campbell S. L., Khosrvi-Far R., Rossman K. L., Clark G. J., Der C. J. Increasing complexity of Ras signaling. Oncogene. 17:1998;1395-1413.
16. Egan S. E., Weinberg R. A. The pathway to signal achievement. Nature. 365:1993;781-783.
17. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell. 77:1994;841-852.
18. Mansour S. J., Matten W. T., Hermann A. S., Candia J. M., Rong S., Fukasawa K., Vande Woude G. F., Ahn N. G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:1994;966-970.
19. v-src. Mol. Cell. Biol. 10:1990;830-836.
20. Okazaki K., Sagata N. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene. 10:1995;1149-1157.
21. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P. H. Gene transfer into mouse glyoma cells by electroporation in high electric fields. EMBO J. 1:1982;841-845.
22. src with Triton X-100-resistant cellular structure correlates with morphological transformation. Proc. Natl. Acad. Sci. USA. 84:1987;2312-2316.
23. Hamaguchi M., Grandori C., Hanafusa H. Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: Analysis by use of anti-phosphotyrosine antibodies. Mol. Cel. Biol. 8:1988;3035-3042.
24. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12:1993;307-314.
25. Overall C. M., Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibloblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J. Biol. Chem. 265:1990;21141-21151.
26. Smith M. R., DeGudicibus S. J., Stacey D. W. Requirement for c-ras proteins during viral oncogene transformation. Nature. 320:1986;540-543.
27. DeClue J. E., Zhang K., Redford P., Vass W. C., Lowy D. R. Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus. Mol. Cell. Biol. 11:1991;2819-2825.
28. Nori M., Vogel U. S., Gibbs J. B., Weber M. J. Inhibition of v-src-induced transformation by a GTPase-activating protein. Mol. Cell. Biol. 11:1991;2812-2818.
29. Aftab D. T., Kwan J., Martin G. S. Ras-independent transformation by v-Src. Proc. Natl. Acad. Sci. USA. 94:1997;3028-3033.
30. Yu C. L., Meyer D. J., Campbell G. S., Larner A. C., Carter-Su C., Schwartz J., Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 269:1995;81-83.
31. Turkson J., Bowman T., Garcia R., Caldenhoven E., De Groot R. P., Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:1998;2545-2552.
32. Bromberg J. F., Horvath C. M., Besser D., Lathem W. W., Darnell J. E. Jr. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:1998;2553-2558.
33. src protein. Mol. Cell. Biol. 9:1989;1651-1658.
34. Penuel E., Martin G. S. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell. 10:1999;1693-1703.
35. Chang H. W., Aoki M., Fruman D., Auger K. R., Bellacosa A., Tsichlis P. N., Cantley L. C., Roberts T. M., Vogt P. K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 276:1997;1848-1850.